Vanessa Menezes

🚨🔥HOT OF PRESS🔥Just check how we integrated #cryobiopsies & Lung Transplants in this interventional surgical trial!! Defining Optimal Settings for Lung Cryobiopsy in End-Stage... : Journal of Bronchology & Interventional Pulmonology journals.lww.com/bronchology/ab…

Always a pleasure to share knowledge regarding #sublobar lung resections with @GBOT_Alerta NORTE/NE crew (& friend). #ThoracicOncology

For every Black woman who has ever wondered if she belongs in neurosurgery — this is what it looks like when you do. Dr. Odette Harris, MD, MPH, Professor of Neurosurgery at Stanford School of Medicine and Director of the Stanford Brain Injury Program, is a global leader in traumatic brain injury care, research, and rehabilitation. With more than 25 years of distinguished service, her work continues to advance both the science of neurotrauma and the pursuit of health equity in neurosurgical care. Her impact is both clinical and cultural. As the Paralyzed Veterans of America Endowed Professor of Spinal Cord Injury Medicine, she made history as the first African American woman in neurosurgery and the first woman at Stanford to receive this honor — a testament to her excellence, leadership, and enduring influence. Her extraordinary contributions have earned national recognition, including the establishment of the Odette Harris Lectureship by the Congress of Neurological Surgeons — an honor reserved for leaders whose work has transformed the field. Because when one Black woman rises in spaces like this, she doesn’t just take a seat at the table — she expands it. At the American Society of Black Neurosurgeons, we proudly celebrate trailblazers like Dr. Harris who embody our mission as The Home of Black Neurosurgical Excellence — advancing leadership, research, and equitable neurosurgical care worldwide. #WomensHistoryMonth #WHM #ASBNOrg #Neurosurgery #ASBNConnects #BlackWomenInMedicine #BlackExcellence

Another year with the best of @GBOT_Alerta for the news surrounding lobar vs sublobar resections for #lungcancers #SAVETHEDATE

Looking for support to attend #WCLC26 in Seoul? Explore IASLC opportunities open now: 🔹Early Career Education Awards 🔹Developing Countries Awards 🔹Nurse/Allied Health Awards 🔹Tobacco Control Awards 🔹IASLC Mentorship Program 🔹Reviewer Workshop 🔹Patient Advocate Awards. Learn more & apply: wclc.iaslc.org/awards/

When you operate bad lung diseases in children your focus on daily setbacks or adulthood problematic switch easy to gain small battles and evolve step by step.

@DrewMoghanaki Always a pleasure to hear the news about @AnkitBharatMD work. Thank you so much for pushing further.

Double lung transplant for advanced COPD following surgery, SBRT, or CRT for stage I-III NSCLC. #TTLC26

As we Brazilian says: work in silence and let your work and professionalism talk. That’s the way we do it.

I’m ready for it!

Patients with unverified lung lesions should not be excluded from #LTx, as only a small proportion of them are malignant. Long-term survival is unaffected, even in case the histology proves an early-stage lung cancer. 🫁 🔗: jhltonline.org/article/S1053-…

Practical approaches to learn from the 5 cases of #LA-NSCLC, which may inspire more thoughts in the future management Thanks for the strong support from MCSC & ART Subcommittee of @IASLC, and great leadership of @DrAlexLouie Team work & collaboration are essential in #MDT 🫁

From @DrHongchengZhu and the @IASLC Advanced Radiation Technology (ART) subcommittee - Practical management of 5 unresectable locally advanced NSCLC cases here ➡️ jto.org/action/showPdf… a☢️🫁🧵...

@DrHongchengZhu @IASLC @JTOonline @DrAlexLouie @_ShankarSiva @finn_corinne @AndrearicFili @LeXiuning Thank you for the inclusion.

The @IASLC MCSC & ART has just published the practical approach for unresctable LA-NSCLC in @JTOonline！ We provides 5 cases representing challenging scenarios for multidisciplinary discussion, inspiring best care for thoracic tumor boards. Read more 👉 tinyurl.com/4ux88xnh

Lung cancer is the #1 cancer killer of men and women in the U.S.—smokers and non-smokers alike. Kills >70k women/ Year vs ~40k with breast cancer. Unlike breast or colon cancer, we still use highly exclusive guidelines that assume only heavy smokers are at risk. Every day: • Never-smokers • Young women with young families • Minorities and others …are dying with advanced lung cancer because they were never eligible for screening. Our new @JAMANetworkOpen study shows: current screening is ineffective and misses most cases. But age-based screening would catch ~94% of lung cancers, reduce disparities, and is cost-effective. If we’re serious about saving lives and achieving health equity, it’s time to fix lung cancer screening urgently. #LungCancer #HealthEquity #Women #Minorities #EarlyDetection jamanetwork.com/journals/jaman…

A novel method to diagnose pulmonary hypertension before major pulmonary surgeries, the PAPUS paper. Thank you to our interventional pulmonology colleagues for their collaboration. doi.org/10.1016/j.xjtc…

Specially where 🌎 🌍 there are some limitations for PET-CTs, as predominance of granulomatosis/inflammatory diseases or when the exam is not largely available.

Nice N-American guidelines about mediastinal staging in the context of #lungcancer but would be great to hear the rest of the world impressions about it.

Reserve mediastinoscopy for cases w discordant CP-EBUS-to-imaging results (eg, nondiagnostic CP-EBUS of large or FDG-avid lymph nodes in a ⬆️-risk patient) or suspicious findings not thoroughly sampled by CP-EBUS. @AAB_IP : journals.lww.com/bronchology/fu…

@ismailsarbay @AATSHQ Can't believe I lost this.

Dr Hiroshi Date from Duke University discussed the techniques of bronchial stump management in a resection case after RT. @AATSHQ

Clinicians can enhance patient understanding by using numerical data instead of verbal probabilities, consistent denominators, absolute risk comparisons, and clear context for unfamiliar data types. ja.ma/42JRNGk